160 related articles for article (PubMed ID: 37920233)
1. New Organotin (IV) Compounds Derived from Dehydroacetic Acid and Thiosemicarbazides: Synthesis, Rational Design, Cytotoxic Evaluation, and Molecular Docking Simulation.
Gómez E; Galván-Hidalgo JM; Pérez-Cuéllar G; Huerta-Landa KA; González-Hernández A; Gómez-García O; Andrade-Pavón D; Ramírez-Apan T; Rodríguez Hernández KD; Hernández S; Cano-Sánchez P; Gómez-Velasco H
Bioinorg Chem Appl; 2023; 2023():7901843. PubMed ID: 37920233
[TBL] [Abstract][Full Text] [Related]
2.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
3. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
4. Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer.
Latsis GK; Banti CN; Kourkoumelis N; Papatriantafyllopoulou C; Panagiotou N; Tasiopoulos A; Douvalis A; Kalampounias AG; Bakas T; Hadjikakou SK
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011935
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(IV) dichloride and its complexes.
Shpakovsky DB; Banti CN; Beaulieu-Houle G; Kourkoumelis N; Manoli M; Manos MJ; Tasiopoulos AJ; Hadjikakou SK; Milaeva ER; Charalabopoulos K; Bakas T; Butler IS; Hadjiliadis N
Dalton Trans; 2012 Dec; 41(48):14568-82. PubMed ID: 23052471
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
[TBL] [Abstract][Full Text] [Related]
7. Pentacoordinated Organotin(IV) Complexes as an Alternative in the Design of Highly Efficient Optoelectronic and Photovoltaic Devices: Synthesis and Photophysical Characterization.
Sánchez Vergara ME; Gómez E; Toledo Dircio E; Álvarez Bada JR; Cuenca Pérez S; Galván Hidalgo JM; González Hernández A; Hernández Ortega S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982325
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates.
Sirajuddin M; Ali S; McKee V; Akhtar N; Andleeb S; Wadood A
J Photochem Photobiol B; 2019 Aug; 197():111516. PubMed ID: 31170508
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological investigations and Petra/Osiris/Molinspiration (POM) analyses of newly synthesized potentially bioactive organotin(IV) carboxylates.
Tariq M; Sirajuddin M; Ali S; Khalid N; Tahir MN; Khan H; Ansari TM
J Photochem Photobiol B; 2016 May; 158():174-83. PubMed ID: 26974578
[TBL] [Abstract][Full Text] [Related]
10. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
11. Diorganotin(IV) complexes based on tridentate ONO ligands as potential anticancer agents.
Jiang W; Qin Q; Xiao X; Tan Y
J Inorg Biochem; 2022 Jul; 232():111808. PubMed ID: 35421767
[TBL] [Abstract][Full Text] [Related]
12. Dibutyltin(IV) Complexes Derived from L-DOPA: Synthesis, Molecular Docking, Cytotoxic and Antifungal Activity.
Rocha-Del Castillo E; Gómez-García O; Andrade-Pavón D; Villa-Tanaca L; Ramírez-Apan T; Nieto-Camacho A; Gómez E
Chem Pharm Bull (Tokyo); 2018; 66(12):1104-1113. PubMed ID: 30504627
[TBL] [Abstract][Full Text] [Related]
13. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.
Abdel-Rahman LH; Abu-Dief AM; Aboelez MO; Hassan Abdel-Mawgoud AA
J Photochem Photobiol B; 2017 May; 170():271-285. PubMed ID: 28456118
[TBL] [Abstract][Full Text] [Related]
14. Organotin(IV) based anti-HCV drugs: synthesis, characterization and biochemical activity.
Shah FA; Sabir S; Fatima K; Ali S; Qadri I; Rizzoli C
Dalton Trans; 2015 Jun; 44(22):10467-78. PubMed ID: 25978123
[TBL] [Abstract][Full Text] [Related]
15. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
16. One-step preparation, structural assignment, and X-ray study of 2,2-di-n-butyl- and 2,2-diphenyl-6-aza-1,3-dioxa-2-stannabenzocyclononen-4-ones derived from amino acids.
Beltrán HI; Zamudio-Rivera LS; Mancilla T; Santillan R; Farfán N
Chemistry; 2003 May; 9(10):2291-306. PubMed ID: 12772304
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines.
Pantelić NĐ; Božić B; Zmejkovski BB; Banjac NR; Dojčinović B; Wessjohann LA; Kaluđerović GN
Molecules; 2021 May; 26(11):. PubMed ID: 34071809
[TBL] [Abstract][Full Text] [Related]
18. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
Baul TS; Basu S; de Vos D; Linden A
Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
[TBL] [Abstract][Full Text] [Related]
19. Organotin meclofenamic complexes: Synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid - novel anti-tuberculosis agents.
Kovala-Demertzi D; Dokorou V; Primikiri A; Vargas R; Silvestru C; Russo U; Demertzis MA
J Inorg Biochem; 2009 May; 103(5):738-44. PubMed ID: 19237201
[TBL] [Abstract][Full Text] [Related]
20. Tin(IV) cyanoximates: synthesis, characterization, and cytotoxicity.
Gerasimchuk N; Maher T; Durham P; Domasevitch KV; Wilking J; Mokhir A
Inorg Chem; 2007 Sep; 46(18):7268-84. PubMed ID: 17676728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
